Bradykinin-induced pulmonary vasoconstriction is time and inducible nitric oxide synthase dependent in a peritonitis sepsis model

Anesthesia and Analgesia

Volumn 99, Issue 3, 2004, Pages 864-871

  Fischer, Lars G ^a   Hilpert, Jan H ^a   Freise, Hendrik ^a   Wendholt, Doreen ^a   Van Aken, Hugo ^a   Sielenkämper, Andreas W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; LUNG CIRCULATION; LUNG HOMOGENATE; LUNG INJURY; LUNG PERFUSION; LUNG VASOCONSTRICTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SEPSIS; TIME; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; BRADYKININ; ENDOTHELIUM, VASCULAR; LUNG; LYSINE; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PERITONITIS; PULMONARY CIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; VASOCONSTRICTION;

EID: 4143144365     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000133000.65613.F5     Document Type: Article

References (26)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
2. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991;115: 457-69.
3. Fischer LG, Horstman DJ, Hahnenkamp K, et al. Selective iNOS-inhibition attenuates acetylcholine and bradykinin-induced vasoconstriction in lipopolysaccharide-exposed rat lungs. Anesthesiology 1999;91:1724-32.
4. Fischer LG, Horstman DJ, Hollmann MW, et al. Cyclooxygenase inhibitors attenuate bradykinin-induced vasoconstriction in septic isolated rat lungs. Anesth Analg 2000;90:625-31.
5. Wichtermann KA, Baue AE, Chaundry IH. Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 1980;29:189-201.
6. Wang P, Yoo P, Zhou M, et al. Reduction in vascular responsiveness to adrenomedullin during sepsis. J Surg Res 1999;85:59-65.
7. Sielenkamper AW, Chin-Yee IH, Martin CM, et al. Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats. Am J Respir Crit Care Med 1997;156:1066-72.
8. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186-96.
9. Farquhar I, Martin CM, Lam C, et al. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996;61:190-6.
10. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 1998;9:1-11.
11. Lush CW, Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation 2000;7:83-101.
12. Arkovitz MS, Wispe JR, Garcia VF, et al. Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J Pediatr Surg 1996;31:1009-15.
13. Kengatharan KM, De Kimpe SJ, Thiemermann C. Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock. Br J Pharmacol 1996;119:1411-21.
14. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee-American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
15. Scott JA, Mehta S, Duggan M, et al. Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. Am J Respir Crit Care Med 2002;165:1426-32.
16. Schneidkraut MJ, Carlson RW. Bacterial sepsis-induced decrease in lung vascular reactivity to 9,11-dideoxy-11a9a-epoxymethanoprostaglandin F2-α (U46619) in the rat. J Pharmacol Exp Ther 1990;253:1171-6.
17. Li S, Fan SX, McKenna TM. Role of nitric oxide in sepsis-induced hyporeactivity in isolated rat lungs. Shock 1996;5: 122-9.
18. McCormack DG, Mehta S, Tyml K, et al. Pulmonary microvascular changes during sepsis: evaluation using intravital video-microscopy. Microvasc Res 2000;60:131-40.
19. Lee RP, Wang D, Kao SJ, et al. The lung is the major site that produces nitric oxide to induce acute pulmonary oedema in endotoxin shock. Clin Exp Pharmacol Physiol 2001;28:315-20.
20. Carraway MS, Piantadosi CA, Jenkinson CP, et al. Differential expression of arginase and iNOS in the lung in sepsis. Exp Lung Res 1998;24:253-68.
21. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993,9:371-7.
22. Fujii Y, Goldberg P, Hussain SN. Contribution of macrophages to pulmonary nitric oxide production in septic shock. Am J Respir Crit Care Med 1998;157:1645-51.
23. Okamoto I, Abe M, Shibata K, et al. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med 2000;162: 716-22.
24. 6-(1-iminoethyl)lysine. Biochemistry 1998;37:4844-52.
25. Bryant CE, Perretti M, Flower RJ. Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo: a possible role for lipocortin 1. Biochem Pharmacol 1998; 55:279-85.
26. Zhang C, Walker LM, Hinson JA, et al. Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition. J Pharmacol Exp Ther 2000;293: 968-72.